Krebs Non Currrent Assets Other from 2010 to 2024

Stocks . India . 
Stock . Krebs Biochemicals and
KREBSBIO   104.14  8.79  7.78%   
Krebs Biochemicals' Non Currrent Assets Other are decreasing with slightly volatile movements from year to year. Non Currrent Assets Other are estimated to finish at about 169.8 M this year. Non Currrent Assets Other is assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents. View All Fundamentals
 
Non Currrent Assets Other  
First Reported
2009-03-31
Previous Quarter
-1.4 M
Current Value
178.2 M
Quarterly Volatility
159.6 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Krebs Biochemicals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Krebs Biochemicals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 51.5 M, Interest Expense of 41.6 M or Selling General Administrative of 5.7 M, as well as many indicators such as . Krebs financial statements analysis is a perfect complement when working with Krebs Biochemicals Valuation or Volatility modules.
  
This module can also supplement various Krebs Biochemicals Technical models . Check out the analysis of Krebs Biochemicals Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
VVisa Class A
GOOGAlphabet Inc Class C
GOOGAlphabet Inc Class C

Other Information on Investing in Krebs Stock

Krebs Biochemicals financial ratios help investors to determine whether Krebs Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Krebs with respect to the benefits of owning Krebs Biochemicals security.
Balance Sheet
Statement
Details
Profit & Loss
Statement
Details
Cash Flow
Statement
Details
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY